415 Capital

Our focus is on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device, Life Science Tool, Diagnostic and Digital Health sectors. Why Gilmartin Capital? The investing landscape is long on capital and short on insight. Our value extends beyond capital. We possess extensive domain expertise in areas such as strategy, market assessment, and capital markets advisory. Our passion is to avail our experience and network to help you solve problems, drive scientific discovery, help patients and grow. For over two decades, we have amassed a propriety expert network consisting of key opinion leaders across multiple therapeutic verticals and technical specialties, and best-in-class operators in various operational, scientific, and financial areas. In fact, the majority of our fund capital comes from operators like you. The founding partners have decades of experience analyzing and advising healthcare technology companies. We do the math! We want to help you advance your vision.

Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system. About no•et•ic “From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding” Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience. Mission: Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience. Commitment: We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations. Focus: CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.

라플라스파트너스는 초기 단계 기술 기업들의 성장을 돕는 것을 소명으로 여기며, 시장을 확장하는 등 강한 목적의식을 가진 스타트업들과 협력하고 싶습니다. 비전 어떤 문제를 해결하고 세상에 어떤 변화를 가져오고 싶은지, 즉, 미래에 대한 명확한 비전을 그릴 수 있는 팀을 기대합니다. 이유 세상의 많은 문제들 중 왜 ‘그 문제’를 해결하고 싶은지에 대해 납득할 만한 이유가 있는 팀을 선호합니다 가치 ‘비전’과 ‘이유’를 바탕으로 고객에게 얼마나 유의미한 가치를 제공할 수 있는가에 집중합니다. 혁신 기술 라플라스파트너스는 혁신 기술로 문제를 해결하고 새로운 패러다임을 만들어가는 영역에 투자합니다. 바이오·헬스케어 제약, 혁신 진단 기기, 디지털 헬스케어, 건강 기능 식품, 푸드테크 등 소재·부품·장비 2차 전지, 반도체 소재·장비, 에너지, 신소재, 디스플레이, 통신 등 IT 인공지능(AI)의 응용, 전기차, 자율주행, 로봇, 메타버스, 증강현실(AR) 등

We are in the midst of technological shifts at a pace faster than ever before. Calculus VC capitalizes on these shifts to deliver returns and impact. We invest in the Series A and Series B stages of startups in the below sectors: FUTURE OF COMPUTING AND AI Continued advancements in AI will demand new developments in hardware and software. New computing materials and interfaces may emerge. Computing power may be more distributed, and the world will be infinitely more connected. These and more, are our areas of interest: Intelligence beyond language: We expect AI to understand quantitative models and physical phenomenon just as well as it understands language. Large Quantitiative Models are a focus for us. New hardware, materials, and architectures: We expect that demand for computing power will grow exponentially. Quantum computing, as well as distributed computing are expected to grow. We expect advancements in computing materials beyond silicon. Immersive and neural interfaces: These interfaces already exist, we expect they will become more mainstream. Spatial computing, integrating the physical world with digital environments may be our future. COMPUTATIONAL LIFE SCIENCES AND HEALTHTECH Breakthroughs in biology, materials, sensors, and data science are converging to redefine healthcare. Precision and personalization will take center stage as AI enhances how we detect, monitor, and treat disease. Areas of interest include: AI-First Therapeutics and Discovery Platforms: ML-powered platforms designing drugs and biologics via simulation, predictive modeling, and data-rich experimentation. Infrastructure for Programmable Biology: Tools that make biology engineerable – lab automation, bioinformatics, 3D bioprinting, next-gen diagnostics and R&D devices. Continuous, Data-Driven and Personalized Care: Wearables, medical devices, and diagnostics to deliver patient-centric care. These models turn users into real-time data streams, enabling adaptive treatment and personalized interventions. ADVANCED INDUSTRIAL TECHNOLOGIES As we expand the frontiers of possibility, we expect industry to evolve with intelligence, autonomy and environmental sustainability at its core. Areas of focus include: AI and automation in industry: Intelligent machines will optimize production, reduce waste, and enable new workflows. From predictive maintenance to robotic manufacturing, automation will power the next industrial revolution. We support startups enabling this vision. Land, ocean, and space transport and communications: We are interested in advanced materials, robotics, sensors, systems and software that will unlock new frontiers from deep-sea mapping to planetary missions. Resource efficiency: Building the future will demand large reserves of energy and natural resources. Technologies that can serve our energy, food, water, and agricultural needs while supporting a better planet are of interest to us.

Reduced emissions. Smarter packaging. Cutting-edge health tech. Next-generation digitization. Zeon Ventures’ expertise, experience and strength power ideas that enable mobility, healthcare and commerce - while continually moving the world closer to the UN’s 2030 Sustainable Development Goals. Our areas of focus include: Driving potential: Solutions enabling the automotive transition to EVs, including batteries, components, and related infrastructure Manufacturing potential: Green packaging, electronics components alternative plastics, renewable chemicals and beyond Health potential: Sustainable healthcare solutions, including coatings, adhesives, expedients and devices aimed at delivering better patient outcomes Digital potential: Advancing the fundamental digital technologies, we need to drive a sustainable economy: 5G, quantum computing, AI, robotics How Zeon unlocks potential Zeon Ventures brings over 70 years of expertise in science, product manufacturing and global marketing to the table. Our access to partners, industry connections and customers – particularly in healthcare and automobility, are unmatched. And our data-driven approach to better products, ideas, and services is built from the ground up to support the potential of ideas that make the world a better place. Leverage our strength in:Channel access and industry connections Sales support Preferred provider benefits R&D and testing support

Cathay Health is dedicated to investing in companies at the convergence of life sciences, healthcare and technology with positive impact on human health. With a reach spanning key bio and tech hubs around the globe, we help companies scale across borders and access new markets, partners and patients. Our Strategy We back venture- and growth-stage companies with emerging technologies that catalyze groundbreaking advances in healthcare. We fund future leaders in tech-enabled medicine with differentiated approaches and strong intellectual property to personalize care, improve access and lower cost. We invest in Series A to C rounds with the ability to lead or co-invest, and help companies scale across borders. Our Focus AreasLife Science Tools Diagnostics Clinical Trial Innovation New Care Models Novel Devices & Materials Enabling Technologies For Advanced Therapies Why Cathay HealthA global platform catalyzing cross-industry collaboration: Cathay Health is affiliated to Cathay Capital – a global investment platform connecting partners and catalyzing collaborations across Europe, North America and Asia to solve the world’s most pressing challenges. Scaling companies to transform health across borders: Our global network and operating expertise across regions allows us to grow impactful companies that serve patients worldwide. Deep expertise in both healthcare and technology: Our unique expertise allows us to identify investment opportunities with the largest impact on human health and care. Investing & operating at the convergence Our team not only invests – but brings operating experience – at the convergence of life sciences, healthcare and tech. Our expertise uniquely bridges these complementary fields to maximize the potential of our portfolio companies.